| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novabay Pharmaceuticals, Inc. (NBY) has 4 insiders with recent SEC Form 4 filings, including 5 buys and 2 sells. NBY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 56.81M | $110.77M | - | |
| 10% | 56.81M | $110.77M | - | |
| 10% | 6.39M | $12.46M | - | |
| CEO | 4.12M | $8.03M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2019 | Wu Mijia | Director | Sell | 63,492 | $2.53 | $160,793.49 | -100% | |
| Aug 20, 2015 | Najafi Ramin | Chief Executive Officer | Buy | 12,000 | $0.47 | $5,640.00 | +200.0% | |
| Mar 3, 2015 | Najafi Ramin | Chief Executive Officer | Buy | 166,666 | $0.60 | $99,999.60 | +5.2% | |
| Mar 3, 2015 | Pioneer Pharma (singapore) Pte. Ltd. | 10% Owner | Buy | 2,590,000 | $0.60 | $1,554,000.00 | +37.0% | |
| Mar 3, 2015 | Sieczkarek Mark M | Director | Buy | 166,666 | $0.60 | $99,999.60 | +559.3% |